INS and type 2 diabetes mellitus: The LADA International Expert Panel recommended to measure serum C-peptide levels as a proxy of insulin secretion in patients with positive islet cell-associated autoantibodies (21, 22), since the decline rate of C-peptide in LADA is midway between T1DM and T2DM (5, 23, 24).